• Hexamethonium Bromide: Mechanistic Dissection of Autonomic C

  2026-08-05

  Explore how Hexamethonium Bromide, a selective antagonist of neuronal-type nicotinic AChR, enables mechanistic insights into autonomic ganglia function and sex-specific hypertension research. This article uniquely bridges granular pharmacology with experimental strategy for advanced neuronal signaling investigations.

• Evaluating Drug Responses in Cancer: Insights from Advanced

  2026-08-05

  Schwartz's dissertation presents a rigorous analysis of in vitro methods for distinguishing between drug-induced cell death and growth inhibition in cancer research. By clarifying the differential measurement of relative and fractional viability, the study provides a framework for more precise evaluation of anticancer agents and their mechanistic effects.

• SIRT1 Regulates Centriole Duplication via Plk2 Deacetylation

  2026-08-04

  The referenced study uncovers the role of SIRT1 in controlling centriole duplication by targeting the centrosome protein Plk2 for deacetylation and subsequent degradation. This mechanistic insight links acetylation status to centrosome homeostasis, with implications for understanding chromosomal instability in cancer.

• Cdk1–PP2A Phospho-Switch Orchestrates Atypical E2F Degradati

  2026-08-04

  This study reveals how coordinated phosphorylation by Cdk1 and dephosphorylation by PP2A constitute a molecular switch regulating the timely proteolysis of atypical E2F transcription factors during the cell cycle. The work advances understanding of protein phosphorylation analysis in cell cycle control, with implications for dissecting regulatory protein turnover.

• Apicidin Impairs Oocyte Maturation via Meiotic and Epigeneti

  2026-08-03

  A recent study reveals that Apicidin, a selective histone deacetylase inhibitor and emerging mycotoxin, compromises oocyte quality by disrupting the meiotic apparatus and altering histone acetylation. These findings provide new mechanistic insights into reproductive toxicity and raise concerns for food safety and experimental design in epigenetics research.

• XXLP Targets NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerative

  2026-08-03

  Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates a novel ability to attenuate ulcerative colitis via modulation of the NOX2/ROS/mitochondria/NLRP3 axis and restoration of gut microbiota balance. This integrated approach highlights potential avenues for improved therapeutic strategies and mechanistic research in colitis and related inflammatory disorders.

• CB-839 (Telaglenastat): Enhancing Cancer Metabolism Workflow

  2026-08-02

  CB-839 (Telaglenastat) unlocks precise control of glutamine metabolism in preclinical cancer models, enabling high-fidelity glutaminolysis inhibition and robust readouts for apoptosis and autophagy. This guide synthesizes breakthrough assay designs, experimental protocols, and troubleshooting strategies to empower translational research teams.

• 4-Hydroxytamoxifen: Technical Guidance for Cancer and Cardia

  2026-08-01

  4-Hydroxytamoxifen (SKU B6167) offers a high-purity, DMSO-soluble estrogen receptor modulator for research applications in breast and prostate cancer, apoptosis assays, and cardiac myocyte calcium handling studies. It is unsuitable for protocols requiring water or ethanol solubility and demands careful storage and preparation to ensure reproducible results.

• Telmisartan: Angiotensin II Receptor Antagonist for Cardiac

  2026-07-31

  Telmisartan is a potent angiotensin II receptor antagonist widely used in hypertension and cardiovascular disease research. It selectively blocks AT1 receptors, inhibiting vasoconstriction and aldosterone secretion, and has been benchmarked in cardiac hypertrophy models. Its solubility and stability properties make it suitable for robust in vitro and in vivo experimental workflows.

• Ozone Stimulates Macrophage Efferocytosis to Relieve Neuropa

  2026-07-31

  This study demonstrates that ozone therapy alleviates neuropathic pain by promoting macrophage efferocytosis through the AMPK/Gas6-MerTK/SOCS3 pathway. The findings provide mechanistic insight into apoptotic cell clearance and neuroinflammation, identifying new therapeutic targets for neuropathic pain.

• Mifepristone (RU486): Molecular Pathways and Precision in On

  2026-07-30

  Explore Mifepristone (RU486) as a precision tool for dissecting progesterone receptor signaling and tumor suppression. This article offers advanced mechanistic insights and protocol guidance for cancer and reproductive biology, uniquely contextualized by recent nuclear receptor research.

• Tariquidar (XR9576): Potent P-gp Inhibition in Drug Resistan

  2026-07-30

  Tariquidar (XR9576) is a high-affinity noncompetitive inhibitor of P-glycoprotein (P-gp), widely used to dissect ABC transporter-mediated drug resistance. Its nanomolar potency and selectivity enable robust modulation of chemoresistance in both conventional and high-viscosity tumor models.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-07-29

  This study introduces a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors with strong in vitro and in vivo efficacy. By targeting metabolic pathways central to diabetes, allergy, and cancer, these compounds offer promising directions for the development of oral therapies for diverse metabolic diseases.

• Palmitic acid (Hexadecanoic Acid): Protocol and Workflow Gui

  2026-07-29

  Palmitic acid (SKU N2456) offers a high-purity, well-characterized saturated long-chain fatty acid for studies involving lipid metabolism, metabolic disorder research, and protein palmitoylation. It is not suitable for aqueous protocols or for long-term storage in solution, requiring precise solvent use and workflow discipline to maintain reproducibility.

• RITA (NSC 652287): Optimizing Tumor Xenograft and Apoptosis

  2026-07-28

  RITA (NSC 652287) offers precise MDM2-p53 inhibition, enabling selective cytotoxicity and robust p53 pathway activation in cancer biology. This article translates recent in vitro and in vivo findings into actionable workflows and troubleshooting guidance, maximizing the compound’s impact in apoptosis assays and tumor xenograft models.

453 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page